Staff Writer
The New York firm ff Venture Capital has historically been adverse to investing in traditional healthcare startups, but Partner David Teten sees new ways to invest
The late-stage firm is set to hold a first and final close on April 21 for its latest fund that is targeted at $1.2 billion
Value of deals, M&A and IPOs all down in month-over-month totals
Trident, Vesalius and other VCs place their bets on concierge care and telemedicine
Options are available for GPs and LPs when funds reach the end of their term
The German firm, with strong ties to the Rocket Internet incubator, will invest in all stages with its near $330 million fund
Bryan Hale, who recently rejoined DFJ as an EIR, talks about how ad hoc tooling is a good sign
Manhattan Venture Partners launches, helping to connect investors with pre-IPO startups as they stay private longer and at higher valuations
The company, backed by Sofinnova and T. Rowe Price among others, raised $161 million in its IPO
The Lucas Venture Group-backed med tech company raised $65 million in its IPO